Effect and safety of transrectal 137 CS gamma-rays in the treatment of benign prostatic hyperplasia.
- Author:
Xin LI
1
;
Ning-chen LI
;
Gang WANG
;
Yan-qun NA
Author Information
- Publication Type:Journal Article
- MeSH: Aged; Aged, 80 and over; Cesium Radioisotopes; therapeutic use; Gamma Rays; therapeutic use; Humans; Male; Middle Aged; Prostatic Hyperplasia; radiotherapy; Quality of Life; Urodynamics
- From: National Journal of Andrology 2006;12(6):525-527
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo evaluate the effect and safety of transrectal 137Cs gamma-ray therapy for benign prostatic hyperplasia.
METHODSThirty cases of BPH were treated by transrectal 137Cs gamma-rays.
RESULTSAfter 6 months there was significant improvement in the maximum urine flow, IPSS and QOL (P < 0.05). But no significant changes were observed in the prostate volume and residual urine (P > 0.05).
CONCLUSIONTransrectal 137Cs gamma-ray therapy is safe and effective in the treatment of BPH.
